We reviewed antibody titers to Mycoplasma pneumoniae and Legionella pneumophila serogroup I in sera from 1,060 cases of acute respiratory infection to determine whether there was an association in seroreactivity to these organisms. Of the 170 serum pairs with antibodies to L. pneumophila (35 seroconversions and 135 with presumptive titers), 32 (14) . Because of the reliance on this retrospective serological test, the association between Mycoplasma pneumoniae seroreactivity and L. pneumophila infections reported by Grady and Gilfillan (2) is of particular concern. These authors reported that significant titers of complement-fixing antibody to M. pneumoniae occurred in 22 of 27 cases of serologically diagnosed Legionnaires disease.
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To assess the frequency and importance of serological coreactivity between L. pneumophila and M. pneumoniae, we reviewed the reactivities of the sera from 1,060 cases of acute respiratory tract infections to both antigens.
MATERIALS AND METHODS Sera. Acute and convalescent sera from 1,060 patients with acute respiratory infections were selected for this study. These sera had been submitted to the University Hygienic Laboratory between 1971 and 1978 for diagnostic serological tests. The sera received between 1971 and 1977 were assayed on receipt for antibodies to M. pneumoniae and were then stored at -25°C in tightly sealed, screw-capped vials until they were tested for antibodies to L. pneumophila in 1978. Sera submitted during 1978 were assayed on recipt for antibodies to M. pneumoniae and L. pneumophila. Antibody assays. Antibodies to L. pneumophila were assayed by the immunofluorescence antibody test, using the method of McDade et al. (9) and either diethyl ether-killed or heat-killed L. pneumophila serogroup I (Philadelphia I) as the antigen. The antigens obtained by these two methods yielded comparable titers. The reagents for this test were supplied by the Centers for Disease Control, Atlanta, Ga. We used a standard complement fixation assay to measure antibodies to the lipid antigen of M. pneumoniae (13) .
For the purpose of our analysis, seroconversions were defined as sera with titers that increased at least fourfold between the acute and convalescent phases of illness to levels of at least 1:32 for M. pneumoniae and 1:128 for L. pneumophila. Sera with presumptive antibody titers were defined as those serum pairs in which the standing titer of at least one serum of the pair was 1:32 or more for M. pneumoniae or 1:256 or more for L. pneumophila. Table 1 shows the frequency of M. pneumoniae titers in sera with and without elevated titers against L. pneumophila serogroup I. Of the 35 serum pairs with seroconversions to L. pneumophila, 3 (8.6%) also demonstrated seroconversions to M. pneumoniae, and 14 (10.4%) of 135 sera with presumptive titers to L. pneumophila had seroconversions to M. pneumoniae. There were an additional 111 (12.5%) seroconversions to M. pneumoniae among 890 paired sera from patients with acute respiratory illness without elevated antibody titers to L. pneumophila.
RESULTS
When the percentages of seroconversions to M. pneumoniae found in sera with concomitant seroconversions (8.6%) or elevated titers (10.4%) to L. pneumophila were compared independently with the percentage of seroconversions (12.5%) in sera without titers to L. pneumophila, the ratios were not statistically significant (G test for independence; 0.05 < P < 0.10).
Presumptive titers to M. pneumoniae occurred in 15 (11%) of the 135 presumptive L. pneumophila sera and in 45 (5%) of the 890 negative L. pneumophila sera. None of the 35 sera pairs that had fourfold increases in antibody titers to L. pneumophila had elevated titers to M. pneumoniae. These differences were not statistically significant (0.05 < P < 0.10).
To confirm and expand these data, we determined the frequencies of L. pneumophila seroreactivity in sera positive for M. pneumoniae and in sera not positive for M. pneumoniae ( The results of this study indicate that there is no statistically significant increased frequency of titers to M. pneumoniae in sera with antibodies to L. pneumophila serogroup I. Furthermore, we could not demonstrate the converse situation (i.e., a significantly greater frequency of L. pneumophila seroreactivity in sera from patients with antibody titers to M. pneumoniae).
The difference between our results and those of Grady and Gifillan may be explained by the method used to measure complement-fixing antibodies to Mycoplasma. Grady and Gilfillan used whole-cell M. pneumoniae antigen, whereas in this study we used lipid antigen extracted by chloroform-methanol from brothgrown M. pneumoniae. Lipid antigen is less anticomplementary, and greater differences in titer are found between acute and convalescent sera (4) . Differences in case selection, high incidences of simultaneous infections in the Massachusetts patients, and differences in the antigenicities of infecting strains of organisms are alternate explanations that may account for the discordant findings.
Our results agree with those of Wilkinson et al. (15) 
